(19)
(11) EP 1 220 928 A2

(12)

(88) Date of publication A3:
17.01.2002

(43) Date of publication:
10.07.2002 Bulletin 2002/28

(21) Application number: 00967217.1

(22) Date of filing: 02.10.2000
(51) International Patent Classification (IPC)7C12N 15/54, C12N 15/90, C12N 15/63, C12N 15/67, C12N 15/85, C12N 9/10, C12N 5/10, C12N 1/21, A01K 67/027
(86) International application number:
PCT/US0027/065
(87) International publication number:
WO 0123/541 (05.04.2001 Gazette 2001/14)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 30.09.1999 US 156953 P

(71) Applicant: ALEXION PHARMACEUTICALS, INC.
New Haven, CT 06511 (US)

(72) Inventors:
  • FODOR, William, L.
    Madison, CT 06443 (US)
  • RAMSOONDAR, Jagdeece, J.
    Hamilton, NY 13346 (US)

(74) Representative: Maschio, Antonio 
D Young & Co,21 New Fetter Lane
London EC4A 1DA
London EC4A 1DA (GB)

   


(54) COMPOSITIONS AND METHODS FOR ALTERING GENE EXPRESSION